DK164941C - Gaerhybridvektor, transformeret gaercelle samt fremgangsmaade til fremstilling af vaevsplasminogenaktivitor (tpa) - Google Patents

Gaerhybridvektor, transformeret gaercelle samt fremgangsmaade til fremstilling af vaevsplasminogenaktivitor (tpa)

Info

Publication number
DK164941C
DK164941C DK551084A DK551084A DK164941C DK 164941 C DK164941 C DK 164941C DK 551084 A DK551084 A DK 551084A DK 551084 A DK551084 A DK 551084A DK 164941 C DK164941 C DK 164941C
Authority
DK
Denmark
Prior art keywords
gercelle
tpa
transformed
plasminogen activator
tissue plasminogen
Prior art date
Application number
DK551084A
Other languages
English (en)
Other versions
DK551084A (da
DK164941B (da
DK551084D0 (da
Inventor
Bernd Meyhack
Albert Hinnen
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB838331045A external-priority patent/GB8331045D0/en
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DK551084D0 publication Critical patent/DK551084D0/da
Publication of DK551084A publication Critical patent/DK551084A/da
Publication of DK164941B publication Critical patent/DK164941B/da
Application granted granted Critical
Publication of DK164941C publication Critical patent/DK164941C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C12N15/69—Increasing the copy number of the vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/58—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi
    • C12N9/60—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi from yeast
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
DK551084A 1983-11-21 1984-11-20 Gaerhybridvektor, transformeret gaercelle samt fremgangsmaade til fremstilling af vaevsplasminogenaktivitor (tpa) DK164941C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB838331045A GB8331045D0 (en) 1983-11-21 1983-11-21 Synthesis of fibrinolytic agents by yeast
GB8331045 1983-11-21
GB8423112 1984-09-13
GB848423112A GB8423112D0 (en) 1983-11-21 1984-09-13 Synthesis of fibrino lytic agents by yeast

Publications (4)

Publication Number Publication Date
DK551084D0 DK551084D0 (da) 1984-11-20
DK551084A DK551084A (da) 1985-05-22
DK164941B DK164941B (da) 1992-09-14
DK164941C true DK164941C (da) 1993-02-01

Family

ID=26287024

Family Applications (1)

Application Number Title Priority Date Filing Date
DK551084A DK164941C (da) 1983-11-21 1984-11-20 Gaerhybridvektor, transformeret gaercelle samt fremgangsmaade til fremstilling af vaevsplasminogenaktivitor (tpa)

Country Status (17)

Country Link
EP (1) EP0143081B1 (da)
JP (1) JPS6119489A (da)
KR (1) KR930002889B1 (da)
AU (1) AU595478B2 (da)
DD (1) DD229151A5 (da)
DE (1) DE3479520D1 (da)
DK (1) DK164941C (da)
ES (1) ES8609471A1 (da)
FI (1) FI86746C (da)
GR (1) GR80966B (da)
HU (1) HU201115B (da)
IE (1) IE57699B1 (da)
IL (1) IL73568A (da)
NO (1) NO844618L (da)
NZ (1) NZ210266A (da)
PH (1) PH22337A (da)
PT (1) PT79518B (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR78180B (da) * 1982-04-15 1984-09-26 Genentech Inc
US7138505B1 (en) 1984-01-12 2006-11-21 Novartis Vaccines And Diagnostics, Inc. Factor VIII:C nucleic acid molecules
WO1986000637A1 (en) * 1984-07-09 1986-01-30 Integrated Genetics, Inc. Yeast cloning vehicle
DK175327B1 (da) * 1984-10-01 2004-08-23 Integrated Genetics Inc Replicerbar ekspressionsvektor og rekombinant DNA-molekyle, som indkoder aktiv human livmodervævsplasminogen-aktivator, pattedyrscelle transformeret med vektoren og fremgangsmåde til fremstilling af aktiv human vævsplasminogen-aktivator (TPA)
JPS624233A (ja) * 1985-07-01 1987-01-10 Toyobo Co Ltd 組織性プラスミノ−ゲン活性化因子の製造法
JPS6229975A (ja) * 1985-08-01 1987-02-07 Mitsui Toatsu Chem Inc 粗ｔＰＡの精製法
GB8521496D0 (en) * 1985-08-29 1985-10-02 Ciba Geigy Ag Repressible yeast promoters
DE3675724D1 (de) * 1985-09-18 1991-01-03 Green Cross Corp Hefe-promotor und verfahren zur herstellung von heterologen proteinen.
USH2055H1 (en) * 1985-09-20 2002-12-03 Zymogenetics, Inc. Expression of tissue-type plasminogen activator in bacteria
GB8530631D0 (en) 1985-12-12 1986-01-22 Ciba Geigy Ag Thrombin inhibitors
MY101203A (en) * 1985-12-12 1991-08-17 Ucp Gen Pharma Ag Production of thrombin iinhibitors.
US5106741A (en) * 1985-12-20 1992-04-21 The Upjohn Company Tissue plasminogen activator (TPA) analogs
US4898825A (en) * 1986-05-07 1990-02-06 Mitsui Toatsu Chemicals, Incorporated Methods for purification of single-chain and double-chain tissue plasminogen activator
ZA872534B (en) * 1986-05-08 1987-11-25 Phillips Petroleum Co Yeast production of streptokinase
IL82746A (en) * 1986-06-06 1994-10-07 Genentech Inc Process for producing biologically active tissue-type plasminogen activator
JPS6463378A (en) * 1986-08-11 1989-03-09 Mitsui Toatsu Chemicals Separation of single stranded tpa and double standard tpa
GB8621118D0 (en) * 1986-09-01 1986-10-08 Whitbread & Co Plc Stabilised polypeptides
DE3789413T2 (de) 1986-10-03 1994-07-28 Ciba Geigy Ag Lymphokin-ähnliche Peptide.
PT86162B (pt) * 1986-11-21 1990-11-20 Smithkline Beecham Corp Expressao de proteina recombinante
ZA879286B (en) 1986-12-16 1988-10-26 Smith Kline Rit New plasminogen activators
US5149533A (en) * 1987-06-04 1992-09-22 Zymogenetics, Inc. Modified t-PA with kringle-/replaced by another kringle
US5089409A (en) * 1989-09-28 1992-02-18 Monsanto Company Method of increasing specific activity of t-pa
US5326700A (en) * 1990-11-06 1994-07-05 Eli Lilly And Company DNA sequences encoding t-PA derivatives with cleavable sites
US5661001A (en) * 1993-08-04 1997-08-26 Ciba-Geigy Corporation High molecular weight desulphatohirudin
US5981227A (en) 1995-02-09 1999-11-09 Movartis Ag Process for the production of proteins

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4775622A (en) * 1982-03-08 1988-10-04 Genentech, Inc. Expression, processing and secretion of heterologous protein by yeast
AR241654A1 (es) * 1982-05-05 1992-10-30 Genentech Inc Procedimiento para producir activador de plasminogeno de tejido humano.
GB2125047B (en) * 1982-08-09 1986-02-19 Ciba Geigy Ag Yeast hybrid vectors and their use for the production of polypeptides
EP0174835A1 (en) * 1984-09-11 1986-03-19 The Upjohn Company Human tissue plasminogen activator and recombinant DNA compounds
DK175327B1 (da) * 1984-10-01 2004-08-23 Integrated Genetics Inc Replicerbar ekspressionsvektor og rekombinant DNA-molekyle, som indkoder aktiv human livmodervævsplasminogen-aktivator, pattedyrscelle transformeret med vektoren og fremgangsmåde til fremstilling af aktiv human vævsplasminogen-aktivator (TPA)

Also Published As

Publication number Publication date
KR930002889B1 (ko) 1993-04-12
HU201115B (en) 1990-09-28
FI844544L (fi) 1985-05-22
JPS6119489A (ja) 1986-01-28
IL73568A (en) 1992-07-15
PT79518A (en) 1984-12-01
PT79518B (pt) 1986-12-12
DK551084A (da) 1985-05-22
EP0143081B1 (en) 1989-08-23
EP0143081A3 (en) 1987-01-07
NO844618L (no) 1985-05-22
FI844544A0 (fi) 1984-11-19
KR850003733A (ko) 1985-06-26
DE3479520D1 (en) 1989-09-28
FI86746B (fi) 1992-06-30
ES537828A0 (es) 1986-07-16
DK164941B (da) 1992-09-14
AU3571984A (en) 1986-03-20
GR80966B (en) 1985-03-15
DD229151A5 (de) 1985-10-30
PH22337A (en) 1988-08-12
IE842965L (en) 1985-05-21
FI86746C (fi) 1992-10-12
EP0143081A2 (en) 1985-05-29
ES8609471A1 (es) 1986-07-16
DK551084D0 (da) 1984-11-20
HUT36185A (en) 1985-08-28
IL73568A0 (en) 1985-02-28
IE57699B1 (en) 1993-03-10
AU595478B2 (en) 1990-04-05
NZ210266A (en) 1988-11-29

Similar Documents

Publication Publication Date Title
US5108388B1 (en) Laser surgery method
FI841813A7 (fi) Menetelmä N-fosfonometyyliglysiinihapon valmistamiseksi.
DE3882822D1 (de) Verfahren zur betriebsmittellokalisierung in rechnernetzen.
NO831637L (no) System og metode for celleutvalg.
DK265785D0 (da) Radionavigationsanlaeg, isaer for skibe
DE3481453D1 (de) Verfahren zur platzierung von elementen.
ES531754A0 (es) Un metodo para estabilizar un activador de plasminogeno de tejido.
FI792997A7 (fi) Menetelmä entsyymin uudelleenkäyttöä varten.
ES537828A0 (es) Procedimiento para preparar agentes fibrinoliticos
DK438884A (da) Behandlingsstation til en elektrofotografisk informationsskriver
NO842281L (no) System og fremgangsmaate for spredning.
FI844368A7 (fi) Menetelmä ja laite vaahtokappaleiden valmistamiseksi.
DE3486006D1 (de) Verfahren zur herstellung von halbleiterlasern.
DE3381891D1 (de) Stamm von clostridium acetobutylleum und verfahren zur herstellung desselben.
DE3485089D1 (de) Verfahren zur herstellung von halbleitervorrichtungen.
DE3483862D1 (de) Mikrolithographisches verfahren.
FI841994A7 (fi) Vaahdotusmenetelmä.
DE3481320D1 (de) Verfahren zur herstellung von protease-inhibitoren.
DE3486023D1 (de) Verfahren zur herstellung von urokinase zymogen.
FI840690A7 (fi) Menetelmä dihydroksibentseenin selektiiviseksi valmistamiseksi.
DK307384D0 (da) Ny plasminogen-aktivator og fremgangsmaade til fremstilling heraf samt thrombolytisk middel indeholdende samme
DE3482467D1 (de) Verfahren zur oligomerisierung von alpha-olefinen.
DK222284D0 (da) 2-heterocyclyllavalkyl-2-penemforbindelser og salte deraf samt fremgangsmaade til fremstilling deraf
IT8467740A1 (it) Procedimento e mezzi per raffreddare cavità, particolarmente cavità di laser.
DE3483717D1 (de) Verfahren zur herstellung von halbleiterstrukturen.

Legal Events

Date Code Title Description
PBP Patent lapsed